Early diagnosis of HPV-associated disease of the cervix uteri in women aged less than 30 years or older
- 作者: Kogan E.A.1, Faizullina N.M.1, Li J.2, Demura T.A.1, Zharkov N.V.1, Kozachenko A.V.1, Chernova V.F.1, Bairamova G.R.1, Prilepskaya P.V.1
-
隶属关系:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- 期: 编号 9 (2015)
- 页面: 62-67
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247504
- ID: 247504
如何引用文章
详细
全文:
作者简介
Evgeniya Kogan
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: koganevg@gmail.com
MD, PhD Professor, Head of the Pathology Department
Nafisa Faizullina
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: naflsa05@inbox.ru
PhD, senior research associate of the Pathology Department
Jiajing Li
I.M. Sechenov First Moscow State Medical University
Email: greenjing@qq.com
postgraduate student of anatomic pathology department
Tatiana Demura
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: uursula90@gmail.com
MD, PhD, senior research associate of the Pathology Department
Nikolay Zharkov
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: nickzharkov@mail.ru
PhD, researcher, of the Pathology Department
Andrey Kozachenko
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_kozachenko@oparina4.ru
MD, PhD, leading research associate of the Gynecological Department
Victoria Chernova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: cernovav@mail.ru
postgraduate student of Polyclinic Department
Gyuldana Bairamova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: g_bairamova@oparina4.ru
MD, PhD, Head of the Polyclinic Department on clinical work
Prilepskaya Prilepskaya
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: VPrilepskaya@mail.ru
MD, PhD, Head of the Polyclinic Department
参考
- Castle P.E., Fetterman B., Thomas Cox J., Shaber R., Poitras N., Lorey T., Kinney W. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet. Gynecol. 2010; 116(1): 76-84.
- Whitlock E.P, Vesco K.K., Eder M., Lin J.S., Senger C.A., Burda B.U. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive services task force. Ann. Intern. Med. 2011; 155(10): 687-97. W214-5.
- Confortini M., Bergeron C., Desai M., Negri G., Dalla Palma P., Montanari G. et al. Accuracy of liquid based cytology: comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts. Cancer Cytopathol. 2010; 118(4): 203-8.
- Kocken M., Uijterwaal M.H., de Vries A.L., Berkhof J., Ket J.C., Helmerhorst T.J., Meijer C.J. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis. Gynecol. Oncol. 2012; 125(2): 500-7.
- Solomon D., Davey D., Kurman R., Moriarty A., O’Connor D., Prey M. et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16): 2114-9.
- Castle P.E., Sadorra M., Lau T., Aldrich C., Garcia F.A., Kornegay J. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J. Clin. Microbiol. 2009; 47(10): 3344-7.
- Petry K.U., Schmidt D., Scherbring S., Luyten A., Reinecke-Luthge A., Bergeron C. et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol. Oncol. 2011; 121(3): 505-9.
- Fawcett T. An introduction to ROC analysis. Pattern Recognition Letters. 2006; 27: 861-74.
- Kim M.-J., Kim J.J., Kim S. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women. Obstet. Gynecol. Sci. 2013; 56(2): 110-20.
- Mesher D., Cuschieri K., Hibbitts S., Jamison J., Sargent A., Pollock K.G. et al. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation. J. Clin. Pathol. 2015; 68(2): 135-40.
- Tungsrithong N., Kasinpila C., Maneenin C. Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac. J. Cancer Prev. 2014; 15(3): 1497-500.
- Rijkaart D.C., Berkhof J., Rozendaal L., van Kemenade F.J., Bulkmans N.W., Heideman D.A. et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012; 13(1): 78-88.
- Kurian E.M., Caporelli M.L., Baker S., Woda B., Cosar E.F., Hutchinson L. Cervista HR and HPV 16/18 assays vs hybrid capture 2 assay: outcome comparison in women with negative cervical cytology. Am. J. Clin. Pathol. 2011; 136(5): 808-16.
- Arbyn M., Roelens J., Cuschieri K., Cuzick J., Szarewski A., Ratnam S. et al. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. Int. J. Cancer. 2013; 132(1): 101-8.
- Ratnam S., Coutlee F., Fontaine D., Bentley J., Escott N., Ghatage P. et al. APTIMA HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer. J. Clin. Microbiol. 2011; 49(2): 557-64.
- Коган Е.А., Файзуллина Н.М., Цзяцзин Л., Демура Т.А., Козаченко А.В. Эффективность диагностики цервикальной интраэпителиальной неоплазии шейки матки с использованием комплекса методов: жидкостной цитологии, двойного иммуноокрашивания p16/Ki67 и ВПЧ тестирования. Акушерство и гинекология. 2014; 7: 43-7. [Kogan E.A., Faizullina N.M., Li Ts., Demura T.A., Kozachenko A.V. Efficiency of cervical intraepithelial neoplasia diagnosis using a set of methods: liquid-based cytology, p16/Ki-67 dual immunostaining and HPV testing. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2014; 7: 43-7. (in Russian)]
- Arbyn M., Roelens J., Buntinx F. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst. Rev. 2013; (3): CD008054.
- Bergeron C., Giorgi-Rossi P., Cas F., Schiboni M.L., Ghiringhello B., Dalla Palma P. et al. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial. J. Natl. Cancer Inst. 2015; 107(2). pii: dju423.